SIEGALL CLAY B (President and CEO) purchased 5.8% of their position (46.51K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $1000.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/18/2025ACC: 0001167496-25-000006
DirectorOfficer· President and CEO
Since Oct 2023
+46.51K
Net shares
Net buyer
$1000.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
46.51K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+46.51K
Price / share
$21.50
Trade value
$999.99K
% of position
5.8%
12/18/2025
806.74K→853.25K
Total
Net shares
+46.51K
Net value
$999.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | P · Purchase | +46.51K | $21.50 | $999.99K | 5.8% | 806.74K | 853.25K |
| Total | +46.51K | $999.99K | ||||||
Derivative Transactions0
No derivative transactions reported